Biggest News Aggregation in the World
๐Ÿ“ฐ Lars Wegner News

Page 2 - Lars Wegner News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Lars Wegner. Real-time updates on events, politics, business and more.

Investegate |Evaxion Biotech Announcements | Evaxion Biotech: Evaxion Biotech Announces Publication of Clinical Data of EVX-01 Heading into Phase 2b in Collaboration with Merck

Investegate announcements from Evaxion Biotech, Evaxion Biotech Announces Publication of Clinical Data of EVX-01 Heading into Phase 2b in Collaboration with Merck
Corey Davis Lars Wegner Exchange Commission Lifesci Advisors Company Adss Evaxion Biotech Announces Publication

Investegate |Evaxion Biotech Announcements | Evaxion Biotech: Evaxion Biotech Announces Clinical Collaboration to Evaluate Lead Product Candidate with KEYTRUDA® (pembrolizumab) in Patients with Melanoma

Investegate announcements from Evaxion Biotech, Evaxion Biotech Announces Clinical Collaboration to Evaluate Lead Product Candidate with KEYTRUDA® (pembrolizumab) in Patients with Melanoma
United States United Kingdom Corey Davis Lars Wegner Glenns Vraniak Lifesci Advisors

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Evaxion Biotech Presents Paper on Potential of Deep Data on Immune Complex Stability to ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Evaxion Biotech Presents Paper on Potential of Deep Data on Immune Complex Stability to ... Evaxion BiotechApril 20, 2021 GMT COPENHAGEN, Denmark, April 20, 2021 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (Nasdaq: EVAX) (โ€œEvaxionโ€ or the โ€œCompanyโ€), a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies to improve the lives of patients with cancer, bac...
Jens Kringelum Lars Wegner Glenns Vraniak Mary Ann Chang Nature Communications Lifesci Advisors
Source: apnews.com

Evaxion Biotech Announces Q4 and Full-Year 2020 Financial Results and Provides Business Update

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Evaxion Biotech Announces Q4 and Full-Year 2020 Financial Results and Provides Business Update Evaxion BiotechApril 6, 2021 GMT Successfully completed initial public offering on U.S. Nasdaq in February 2021, raising gross proceeds of $30 million Clinical development on track with dosing of first patient in Phase 1/2a melanoma trial of cancer vaccine EVX-02 Cash reserves of $5.8 million at December 31...
United States Lars Wegner Glenns Vraniak Mary Ann Chang Exchange Commission Lifesci Advisors
Source: apnews.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science